Details for New Drug Application (NDA): 073524
✉ Email this page to a colleague
NDA 073524 describes EPITOL, which is a drug marketed by Teva and is included in two NDAs. It is available from two suppliers. Additional details are available on the EPITOL profile page.
The generic ingredient in EPITOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
The generic ingredient in EPITOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 073524
| Tradename: | EPITOL |
| Applicant: | Teva |
| Ingredient: | carbamazepine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 073524
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 100MG | ||||
| Approval Date: | Jul 29, 1992 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
